质瘤和神经瘤的改变:表达模式和治疗含义
Sarra Belakhoua1, Gianluca Lopez2,3,4, Swati Dubey2
1Department of Pathology, New York University, New York City, NY, United States.
Journal of neuropathology and experimental neurology
|November 29, 2025
概括
在中枢神经系统瘤中发现了RECQL4基因变异. 向RECQL4可能会降低瘤存活率,并在质瘤和恶性外围神经瘤中增加对ATR抑制剂的敏感性.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- RECQL4对于基因组完整性和DNA复制至关重要.
- 它在中枢神经系统 (CNS) 瘤中的作用目前尚不清楚.
研究的目的:
- 研究RECQL4在各种中枢神经系统瘤中的作用.
- 探索针对RECQL4与ATR抑制剂结合的治疗潜力.
主要方法:
- 对1580个中枢神经系统瘤进行了测序和免疫组织化学分析.
- 功能性研究涉及RECQL4在质瘤和恶性外围神经膜瘤 (MPNST) 细胞系中的淘汰.
- 细胞系用ATR抑制剂进行治疗.
主要成果:
- 在4.5%的中枢神经系统瘤中发现了RECQL4基因变异,其中29.6%具有潜在的病原性.
- 在不同瘤类型中,RECQL4的表达有显著的差异,通常在低级质瘤中较低,在高级质瘤和神经纤维瘤中较高.
- MPNSTs,特别是零星病例,比NF1相关的MPNSTs显示出更高的RECQL4表达.
- 在质瘤和MPNST细胞系中,RECQL4敲除增加了细胞亡和ATR抑制剂敏感性.
结论:
- 在不同的中枢神经系统瘤中,RECQL4表现出不同的表达模式.
- 准RECQL4是一个潜在的策略,可以抑制瘤生长,并提高ATR抑制剂治疗中枢神经系统瘤的疗效.
更多相关视频
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
8.2K
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.9K
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
